Current status:
Cancelled Post Market
Current status date:
2010-07-13
Product name:
CLONAZEPAM-0.5 - TAB 0.5MG
DIN:
02220598
Electronic product monograph is not available
Company:
PRO DOC LIMITEE
2925 Boulevard Industriel
Laval
Quebec
Canada
H7L 3W9
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Targeted (CDSA IV)
Anatomical Therapeutic Chemical (ATC):
See footnote 4
N03AE01 CLONAZEPAM
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
CLONAZEPAM
|
.5 MG
|